| |
ATC |
 1 Agents affecting nervous system and sensory organs
|
|
|
2 Agents affecting individual organs
|
|
|
3 Agents affecting metabolism
|
|
|
 4 Agents affecting cellular function
|
41 Cellular function activating agents
|
42 Antineoplastics
|
421 Alkylating agents
|
422 Antimetabolites
|
4221 Mercaptopurines
|
4222 Methotrexates
|
4223 Fluorouracils
|
4224 Cytosines
|
4229 Others
|
 D06503 Pemetrexed sodium hydrate (JAN)
D05589 Pralatrexate (JAN/USAN/INN)
D01907 Fludarabine phosphate (JAN/USP)
D03546 Clofarabine (JAN/USAN/INN)
D05134 Nelarabine (JAN/USAN/INN); Nelzarabine (USAN)
D02131 Tegafur and uracil
D06399 Tegafur, gimeracil and oteracil potassium
D00341 Hydroxyurea (USP); Hydroxycarbamide (JAN/INN)
|
L01BA04
L01BA05
L01BB05
L01BB06
L01BB07
L01BC53
L01BC53
L01XX05
|
423 Antibiotics
|
424 Plant extract preparations
|
429 Miscellaneous
|
43 Radioactive drugs
|
44 Allergic agents
|
49 Other agents affecting cellular function
|
|
|
5 Crude drugs and Chinese medicine formulations
|
|
|
6 Agents against pathologic organisms and parasites
|
|
|
7 Agents not mainly for therapeutic purpose
|
|
|
8 Narcotics
|
Therapeutic Category of Drugs in Japan